Patents by Inventor Ragna Hoffmann

Ragna Hoffmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10398705
    Abstract: The invention is directed to a pharmaceutical tablet formulation for the veterinary medical sector containing an instable ACE inhibitor or a pharmaceutically acceptable salt thereof as a first pharmaceutically active substance, and pimobendan or a pharmaceutically acceptable salt thereof as a second pharmaceutically active substance, comprising granules which contain carrier core particles coated with at least one layer wherein the first pharmaceutically active substance is present, the granules being embedded in a tablet matrix wherein the second pharmaceutically active substance is present. It is provided a “fixed-dose-combination” which allows to ease the treatment and administration of the medication, improves the medication compliance by reducing the pill burden to the animal holder and enables the better observation of and adherence to the therapy by decreasing the number of tablets to be administered.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: September 3, 2019
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Martin Folger, Ragna Hoffmann, Florent Robin
  • Publication number: 20160030349
    Abstract: The present invention relates to core-shell nanoparticles, methods for their production, and their use, in particular as adjuvants. Generally, the nanoparticles of the invention comprise a solid core consisting of a biodegradable polymer and a shell of amphiphilic molecules disposed about said core.
    Type: Application
    Filed: July 28, 2015
    Publication date: February 4, 2016
    Inventors: Donny FRANCIS, Alf LAMPRECHT, Martin FOLGER, Ragna HOFFMANN, Alfonso MARTIN-FONTECHA
  • Publication number: 20150064249
    Abstract: The invention is directed to a pharmaceutical tablet formulation for the veterinary medical sector containing an instable ACE inhibitor or a pharmaceutically acceptable salt thereof as a first pharmaceutically active substance, and pimobendan or a pharmaceutically acceptable salt thereof as a second pharmaceutically active substance, comprising granules which contain carrier core particles coated with at least one layer wherein the first pharmaceutically active substance is present, the granules being embedded in a tablet matrix wherein the second pharmaceutically active substance is present. It is provided a “fixed-dose-combination” which allows to ease the treatment and administration of the medication, improves the medication compliance by reducing the pill burden to the animal holder and enables the better observation of and adherence to the therapy by decreasing the number of tablets to be administered.
    Type: Application
    Filed: March 14, 2013
    Publication date: March 5, 2015
    Applicant: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Martin Folger, Ragna Hoffmann, Florent Robin